Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients
Hatixhe Latifi-Pupovci, Sadie Namani, Artina Pajaziti, Blerina Ahmetaj-Shala, Lindita Ajazaj, Afrim Kotori, Valdete Haxhibeqiri, Valentin Gegaj, Gramoz Bunjaku
Scientific Reports, doi:10.1038/s41598-022-09785-7
Several studies have found an association of COVID-19 disease severity with Vitamin D deficiency and higher levels of anti-SARS-CoV-2 IgGs. The aim of this study was to determine whether levels of Vitamin D and "inflammatory state" influence the magnitude of anti-SARS-CoV-2 IgGs levels in COVID-19 patients. For this purpose, in 67 patients levels of anti-SARS-CoV-2 IgG were measured in week 4 whereas in 52 patients levels of Vitamin D were measured in week 1 after symptom onset. We found that low Vitamin D levels were significantly associated with age and disease severity whereas there was a trend without significance, towards negative correlation of Vitamin D with anti-SARS-CoV-2 IgG. Anti-SARS-CoV-2 IgG were significantly higher in older ages, patients with severe disease, diabetes and those who received corticosteroid and antibiotic therapy. There was a positive correlation of anti-SARS-CoV-2 IgG with IL-6, CRP, LDH, ESR and with percentages of granulocytes. In conclusion, Vitamin D and anti-SARS-CoV-2 IgG share common parameters associated with inflammatory state. However, even though Vitamin D protects against severe forms of COVID-19 it could not directly affect anti-SARS-CoV-2 IgG production.
The coronavirus disease 2019 (COVID-19 ) is caused by a new coronavirus which in addition to acute respiratory failure is associated with systemic disorders such as hyperinflammation, hypercoagulation and vasculitis 1 . Although many people exhibit mild 'flu-like' symptoms, in severe responses systemic changes have been attributed to the cytokine storm accompanying severe inflammatory syndrome [2] [3] [4] . Severe forms of COVID-19 have been linked with low levels of circulating 25-hydroxy Vitamin D (25[OH]D) as an expression of Vitamin D (Vit. D) [5] [6] [7] [8] [9] [10] . Vit. D has immunomodulatory activity in response to invasion of bacterial and viral pathogens 11, 12 interacting with its receptor (VDR) in immune cells [13] [14] [15] . In several studies it was shown that severe inflammatory syndrome was accompanied with changes in hematological markers and increased several inflammatory markers such as CRP, LDH, ESR, ferritin etc. 2, [16] [17] [18] . A recent study has shown that in the presence of Vit. D, IL-6 induces higher production of IL-10, a known anti-inflammatory cytokine which is expected to lead to the reduction of inflammatory markers such as CRP 19 . Several studies have shown inverse association between Vit. D and CRP levels [20] [21] [22] . Additionally, high levels of CRP were associated with lowering levels of Vit. D 23 indicating that Vit. D is a negative acute phase reactant. Thus, Vit. D insufficiency could be the cause and effect of high CRP levels in COVID-19 patients. Humoral and cellular immune responses, two wings of adaptive immunity, are crucial in clearing a variety of viral infections 24 , and have been implicated in recovered COVID-19 patients 25, 26 . In several studies disease severity..
Ethics declaration. This study was approved by the Ethics Committee at University Clinical Centre of Kosova (reference no 2548/2020). Written informed consent was obtained from all participants, in accordance with the Declaration of Helsinki.
Author contributions
Competing interests The authors declare no competing interests.
References
Ahmed, A network-based analysis reveals the mechanism underlying vitamin D in suppressing cytokine storm and virus in SARS-CoV-2 infection, Front. Immunol,
doi:10.3389/fimmu.2020.590459Akter, Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh, PLoS Negl. Trop. Dis,
doi:10.1371/journal.pntd.0010102Ali, Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19, J. Med. Virol,
doi:10.1002/jmv.26097Almerighi, 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes, Cytokine,
doi:10.1016/j.cyto.2008.12.009Aoshi, Koyama, Kobiyama, Akira, Ishii, Innate and adaptive immune responses to viral infection and vaccination, Curr. Opin. Virol,
doi:10.1016/j.coviro.2011.07.002Barassi, Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support, Panminerva Med,
doi:10.23736/S0031-0808.21.04277-4Bellia, Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects, Intern. Emerg. Med,
doi:10.1007/s11739-011-0559-xCarpagnano, Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J. Endocrinol. Investig,
doi:10.1007/s40618-020-01370-xChadha, Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients, Prostate,
doi:10.1002/pros.21250Charoenngam, Holick, Immunologic effects of vitamin D on human health and disease, Nutrients,
doi:10.3390/nu12072097Cruz, Interleukin-6 Is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 oxi, Front. Immunol,
doi:10.3389/fimmu.2021.613422Daneshkhah, Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients, Aging Clin. Exp. Res,
doi:10.1007/s40520-020-01677-yDemir, Demir, Aygun, Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease, J. Med. Virol,
doi:10.1002/jmv.26832Esperança-Martins, Humoral immune response of SARS-CoV-2-infected patients with cancer: Influencing factors and mechanisms, Oncologist,
doi:10.1002/onco.13828Figueiredo-Campos, Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset, Eur. J. Immunol,
doi:10.1002/eji.202048970Gao, The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity, Signal Transduct. Target Ther,
doi:10.1038/s41392-021-00525-3Ghasemian, The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis, Int. J. Clin. Pract,
doi:10.1111/ijcp.14675Ghashut, Talwar, Kinsella, Duncan, Mcmillan, The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin, PLoS One,
doi:10.1371/journal.pone.0092614Gozalbo-Rovira, SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients, J. Clin. Virol,
doi:10.1016/j.jcv.2020.104611Hoepel, High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages, Sci. Transl. Med,
doi:10.1126/scitranslmed.abf8654Honardoost, Ghavideldarestani, Khamseh, Role of Vitamin D in pathogenesis and severity of COVID-19 infection, Arch. Physiol. Biochem,
doi:10.1080/13813455.2020.1792505Ibarrondo, Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild covid-19, N. Engl. J. Med,
doi:10.1056/NEJMc2025179Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin. Exp. Res,
doi:10.1007/s40520-020-01570-8Jain, Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Sci. Rep,
doi:10.1038/s41598-020-77093-zKalia, Studzinski, Sarkar, Role of Vitamin D in regulating COVID-19 severity-An immunological perspective, J. Leukoc. Biol,
doi:10.1002/JLB.4COVR1020-698RKaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One,
doi:10.1371/journal.pone.0239252Kebapcilar, Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency, Arch. Gynecol. Obstet,
doi:10.1007/s00404-013-2735-xKerget, Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis. COVID-19 hastalarında serum vitamin D düzeyinin klinik seyir ve prognozla ilişkisinin değerlendirilmesi, Tuberk Toraks,
doi:10.5578/tt.70027Kutsuna, Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19, J. Infect. Chemother,
doi:10.1016/j.jiac.2021.01.006Li, Patient and clinical factors at admission affect the levels of neutralizing antibodies six months after recovering from COVID-19, Viruses,
doi:10.3390/v14010080Ma, Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge, Sci. China Life Sci,
doi:10.1007/s11427-020-1805-0Marklund, Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG nonresponders, PLoS ONE,
doi:10.1371/journal.pone.0241104Mellenthin, Association between serum vitamin D concentrations and inflammatory markers in the general adult population, Metabolism,
doi:10.1016/j.metabol.2014.05.002Moutchia, Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis, PLoS One,
doi:10.1371/journal.pone.0239802Munshi, Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J. Med. Virol,
doi:10.1002/jmv.26360Olbei, SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely ill patients, Front. Immunol,
doi:10.3389/fimmu.2021.629193Palaniswamy, Could vitamin D reduce obesity-associated inflammation? Observational and Mendelian randomization study, Am. J. Clin. Nutr,
doi:10.1093/ajcn/nqaa056Thomson, Toscano-Guerra, Casis, Paciucci, C1 esterase inhibitor and the contact system in COVID-19, Br. J. Haematol,
doi:10.1111/bjh.16938Tjendra, Predicting disease severity and outcome in COVID-19 patients: A review of multiple biomarkers, Arch. Pathol. Lab. Med,
doi:10.5858/arpa.2020-0471-SATo, Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study, Lancet Infect. Dis,
doi:10.1016/S1473-3099(20)30196-1Yisak, Effects of Vitamin D on COVID-19 infection and prognosis: A systematic review, Risk Manag. Healthc. Policy,
doi:10.2147/RMHP.S291584Zhao, A comparative study of the laboratory features of COVID-19 and other viral pneumonias in the recovery stage, J. Clin. Lab. Anal,
doi:10.1002/jcla.23483Zhao, Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019, Clin. Infect. Dis,
doi:10.1093/cid/ciaa344{ 'indexed': {'date-parts': [[2022, 4, 5]], 'date-time': '2022-04-05T17:45:17Z', 'timestamp': 1649180717741},
'reference-count': 63,
'publisher': 'Springer Science and Business Media LLC',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2022, 4, 5]],
'date-time': '2022-04-05T00:00:00Z',
'timestamp': 1649116800000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0'},
{ 'start': { 'date-parts': [[2022, 4, 5]],
'date-time': '2022-04-05T00:00:00Z',
'timestamp': 1649116800000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0'}],
'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False},
'short-container-title': ['Sci Rep'],
'published-print': {'date-parts': [[2022, 12]]},
'abstract': '<jats:title>Abstract</jats:title><jats:p>Several studies have found an association of '
'COVID-19 disease severity with Vitamin D deficiency and higher levels of anti-SARS-CoV-2 '
'IgGs. The aim of this study was to determine whether levels of Vitamin D and “inflammatory '
'state” influence the magnitude of anti-SARS-CoV-2 IgGs levels in COVID-19 patients. For this '
'purpose, in 67 patients levels of anti-SARS-CoV-2 IgG were measured in week 4 whereas in 52 '
'patients levels of Vitamin D were measured in week 1 after symptom onset. We found that low '
'Vitamin D levels were significantly associated with age and disease severity whereas there '
'was a trend without significance, towards negative correlation of Vitamin D with '
'anti-SARS-CoV-2 IgG. Anti-SARS-CoV-2 IgG were significantly higher in older ages, patients '
'with severe disease, diabetes and those who received corticosteroid and antibiotic therapy. '
'There was a positive correlation of anti-SARS-CoV-2 IgG with IL-6, CRP, LDH, ESR and with '
'percentages of granulocytes. In conclusion, Vitamin D and anti-SARS-CoV-2 IgG share common '
'parameters associated with inflammatory state. However, even though Vitamin D protects '
'against severe forms of COVID-19 it could not directly affect anti-SARS-CoV-2 IgG '
'production.</jats:p>',
'DOI': '10.1038/s41598-022-09785-7',
'type': 'journal-article',
'created': {'date-parts': [[2022, 4, 5]], 'date-time': '2022-04-05T17:03:16Z', 'timestamp': 1649178196000},
'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': [ 'Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in '
'COVID-19 patients'],
'prefix': '10.1038',
'volume': '12',
'author': [ {'given': 'Hatixhe', 'family': 'Latifi-Pupovci', 'sequence': 'first', 'affiliation': []},
{'given': 'Sadie', 'family': 'Namani', 'sequence': 'additional', 'affiliation': []},
{'given': 'Artina', 'family': 'Pajaziti', 'sequence': 'additional', 'affiliation': []},
{'given': 'Blerina', 'family': 'Ahmetaj-Shala', 'sequence': 'additional', 'affiliation': []},
{'given': 'Lindita', 'family': 'Ajazaj', 'sequence': 'additional', 'affiliation': []},
{'given': 'Afrim', 'family': 'Kotori', 'sequence': 'additional', 'affiliation': []},
{'given': 'Valdete', 'family': 'Haxhibeqiri', 'sequence': 'additional', 'affiliation': []},
{'given': 'Valentin', 'family': 'Gegaj', 'sequence': 'additional', 'affiliation': []},
{'given': 'Gramoz', 'family': 'Bunjaku', 'sequence': 'additional', 'affiliation': []}],
'member': '297',
'published-online': {'date-parts': [[2022, 4, 5]]},
'reference': [ { 'issue': '4',
'key': '9785_CR1',
'doi-asserted-by': 'publisher',
'first-page': '520',
'DOI': '10.1111/bjh.16938',
'volume': '190',
'author': 'TM Thomson',
'year': '2020',
'unstructured': 'Thomson, T. M., Toscano-Guerra, E., Casis, E. & Paciucci, R. C1 esterase '
'inhibitor and the contact system in COVID-19. Br. J. Haematol. 190(4), '
'520–524. https://doi.org/10.1111/bjh.16938 (2020).',
'journal-title': 'Br. J. Haematol.'},
{ 'key': '9785_CR2',
'doi-asserted-by': 'publisher',
'DOI': '10.3389/fimmu.2021.613422',
'volume': '12',
'author': 'A Santa Cruz',
'year': '2021',
'unstructured': 'Santa Cruz, A. et al. Interleukin-6 Is a biomarker for the development '
'of fatal severe acute respiratory syndrome coronavirus 2 oxi. Front. '
'Immunol. 12, 613422. https://doi.org/10.3389/fimmu.2021.613422 (2021).',
'journal-title': 'Front. Immunol.'},
{ 'key': '9785_CR3',
'doi-asserted-by': 'publisher',
'DOI': '10.3389/fimmu.2021.629193',
'volume': '12',
'author': 'M Olbei',
'year': '2021',
'unstructured': 'Olbei, M. et al. SARS-CoV-2 causes a different cytokine response '
'compared to other cytokine storm-causing respiratory viruses in severely '
'ill patients. Front. Immunol. 12, 629193. '
'https://doi.org/10.3389/fimmu.2021.629193 (2021).',
'journal-title': 'Front. Immunol.'},
{ 'key': '9785_CR4',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.micpath.2021.104799',
'volume': '153',
'author': 'D Darif',
'year': '2021',
'unstructured': 'Darif, D. et al. The pro-inflammatory cytokines in COVID-19 '
'pathogenesis: What goes wrong?. Microb. Pathog. 153, 104799. '
'https://doi.org/10.1016/j.micpath.2021.104799 (2021).',
'journal-title': 'Microb. Pathog.'},
{ 'issue': '10',
'key': '9785_CR5',
'doi-asserted-by': 'publisher',
'first-page': '1373',
'DOI': '10.1016/j.jiph.2020.06.021',
'volume': '13',
'author': 'N Ali',
'year': '2020',
'unstructured': 'Ali, N. Role of vitamin D in preventing of COVID-19 infection, '
'progression and severity. J. Infect. Public Health. 13(10), 1373–1380. '
'https://doi.org/10.1016/j.jiph.2020.06.021 (2020).',
'journal-title': 'J. Infect. Public Health.'},
{ 'key': '9785_CR6',
'doi-asserted-by': 'publisher',
'DOI': '10.3389/fimmu.2020.590459',
'volume': '11',
'author': 'F Ahmed',
'year': '2020',
'unstructured': 'Ahmed, F. A network-based analysis reveals the mechanism underlying '
'vitamin D in suppressing cytokine storm and virus in SARS-CoV-2 '
'infection. Front. Immunol. 11, 590459. '
'https://doi.org/10.3389/fimmu.2020.590459 (2020).',
'journal-title': 'Front. Immunol.'},
{ 'key': '9785_CR7',
'doi-asserted-by': 'publisher',
'author': 'M Honardoost',
'year': '2020',
'unstructured': 'Honardoost, M., Ghavideldarestani, M. & Khamseh, M. E. Role of Vitamin D '
'in pathogenesis and severity of COVID-19 infection. Arch. Physiol. '
'Biochem. https://doi.org/10.1080/13813455.2020.1792505 (2020).',
'journal-title': 'Arch. Physiol. Biochem.',
'DOI': '10.1080/13813455.2020.1792505'},
{ 'issue': '7',
'key': '9785_CR8',
'doi-asserted-by': 'publisher',
'first-page': '1195',
'DOI': '10.1007/s40520-020-01570-8',
'volume': '32',
'author': 'PC Ilie',
'year': '2020',
'unstructured': 'Ilie, P. C., Stefanescu, S. & Smith, L. The role of vitamin D in the '
'prevention of coronavirus disease 2019 infection and mortality. Aging '
'Clin. Exp. Res. 32(7), 1195–1198. '
'https://doi.org/10.1007/s40520-020-01570-8 (2020).',
'journal-title': 'Aging Clin. Exp. Res.'},
{ 'issue': '4',
'key': '9785_CR9',
'doi-asserted-by': 'publisher',
'first-page': '809',
'DOI': '10.1002/JLB.4COVR1020-698R',
'volume': '110',
'author': 'V Kalia',
'year': '2021',
'unstructured': 'Kalia, V., Studzinski, G. P. & Sarkar, S. Role of Vitamin D in '
'regulating COVID-19 severity—An immunological perspective. J. Leukoc. '
'Biol. 110(4), 809–819. https://doi.org/10.1002/JLB.4COVR1020-698R '
'(2021).',
'journal-title': 'J. Leukoc. Biol.'},
{ 'key': '9785_CR10',
'doi-asserted-by': 'publisher',
'first-page': '31',
'DOI': '10.2147/RMHP.S291584',
'volume': '14',
'author': 'H Yisak',
'year': '2021',
'unstructured': 'Yisak, H. et al. Effects of Vitamin D on COVID-19 infection and '
'prognosis: A systematic review. Risk Manag. Healthc. Policy. 14, 31–38. '
'https://doi.org/10.2147/RMHP.S291584 (2021).',
'journal-title': 'Risk Manag. Healthc. Policy.'},
{ 'issue': '7',
'key': '9785_CR11',
'doi-asserted-by': 'publisher',
'first-page': '2097',
'DOI': '10.3390/nu12072097',
'volume': '12',
'author': 'N Charoenngam',
'year': '2020',
'unstructured': 'Charoenngam, N. & Holick, M. F. Immunologic effects of vitamin D on '
'human health and disease. Nutrients 12(7), 2097. '
'https://doi.org/10.3390/nu12072097 (2020).',
'journal-title': 'Nutrients'},
{ 'issue': '11',
'key': '9785_CR12',
'doi-asserted-by': 'publisher',
'first-page': '1656',
'DOI': '10.3390/nu10111656',
'volume': '10',
'author': 'F Sassi',
'year': '2018',
'unstructured': 'Sassi, F., Tamone, C. & D’Amelio, P. Vitamin D: nutrient, hormone, and '
'immunomodulator. Nutrients 10(11), 1656. '
'https://doi.org/10.3390/nu10111656 (2018).',
'journal-title': 'Nutrients'},
{ 'issue': '4',
'key': '9785_CR13',
'doi-asserted-by': 'publisher',
'first-page': '368',
'DOI': '10.1002/pros.21250',
'volume': '71',
'author': 'MK Chadha',
'year': '2011',
'unstructured': 'Chadha, M. K. et al. Effect of 25-hydroxyvitamin D status on serological '
'response to influenza vaccine in prostate cancer patients. Prostate '
'71(4), 368–372. https://doi.org/10.1002/pros.21250 (2011).',
'journal-title': 'Prostate'},
{ 'issue': '10',
'key': '9785_CR14',
'doi-asserted-by': 'publisher',
'first-page': '2141',
'DOI': '10.1007/s40520-020-01677-y',
'volume': '32',
'author': 'A Daneshkhah',
'year': '2020',
'unstructured': 'Daneshkhah, A. et al. Evidence for possible association of vitamin D '
'status with cytokine storm and unregulated inflammation in COVID-19 '
'patients. Aging Clin. Exp. Res. 32(10), 2141–2158. '
'https://doi.org/10.1007/s40520-020-01677-y (2020).',
'journal-title': 'Aging Clin. Exp. Res.'},
{ 'issue': '6',
'key': '9785_CR15',
'doi-asserted-by': 'publisher',
'first-page': '856',
'DOI': '10.1038/s41430-020-0661-0',
'volume': '74',
'author': 'M Ebadi',
'year': '2020',
'unstructured': 'Ebadi, M. & Montano-Loza, A. J. Perspective: Improving vitamin D status '
'in the management of COVID-19. Eur. J. Clin. Nutr. 74(6), 856–859. '
'https://doi.org/10.1038/s41430-020-0661-0 (2020).',
'journal-title': 'Eur. J. Clin. Nutr.'},
{ 'issue': '7',
'key': '9785_CR16',
'doi-asserted-by': 'publisher',
'first-page': '834',
'DOI': '10.1002/ajh.25829',
'volume': '95',
'author': 'E Terpos',
'year': '2020',
'unstructured': 'Terpos, E. et al. Hematological findings and complications of COVID-19. '
'Am. J. Hematol. 95(7), 834–847. https://doi.org/10.1002/ajh.25829 '
'(2020).',
'journal-title': 'Am. J. Hematol.'},
{ 'issue': '10',
'key': '9785_CR17',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0239802',
'volume': '15',
'author': 'J Moutchia',
'year': '2020',
'unstructured': 'Moutchia, J. et al. Clinical laboratory parameters associated with '
'severe or critical novel coronavirus disease 2019 (COVID-19): A '
'systematic review and meta-analysis. PLoS\xa0One 15(10), e0239802. '
'https://doi.org/10.1371/journal.pone.0239802 (2020).',
'journal-title': 'PLoS\xa0One'},
{ 'key': '9785_CR18',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.jcv.2020.104611',
'volume': '131',
'author': 'R Gozalbo-Rovira',
'year': '2020',
'unstructured': 'Gozalbo-Rovira, R. et al. SARS-CoV-2 antibodies, serum inflammatory '
'biomarkers and clinical severity of hospitalized COVID-19 patients. J. '
'Clin. Virol. 131, 104611. https://doi.org/10.1016/j.jcv.2020.104611 '
'(2020).',
'journal-title': 'J. Clin. Virol.'},
{ 'key': '9785_CR19',
'doi-asserted-by': 'publisher',
'author': 'R McGregor',
'year': '2020',
'unstructured': 'McGregor, R. et al. An autocrine vitamin D-driven Th1 shutdown program '
'can be exploited for COVID-19. Preprint. bioRxiv '
'https://doi.org/10.1101/2020.07.18.210161 (2020).',
'journal-title': 'bioRxiv',
'DOI': '10.1101/2020.07.18.210161'},
{ 'issue': '8',
'key': '9785_CR20',
'doi-asserted-by': 'publisher',
'first-page': '1056',
'DOI': '10.1016/j.metabol.2014.05.002',
'volume': '63',
'author': 'L Mellenthin',
'year': '2014',
'unstructured': 'Mellenthin, L. et al. Association between serum vitamin D concentrations '
'and inflammatory markers in the general adult population. Metabolism '
'63(8), 1056–1062. https://doi.org/10.1016/j.metabol.2014.05.002 (2014).',
'journal-title': 'Metabolism'},
{ 'issue': '5',
'key': '9785_CR21',
'doi-asserted-by': 'publisher',
'first-page': '1036',
'DOI': '10.1093/ajcn/nqaa056',
'volume': '111',
'author': 'S Palaniswamy',
'year': '2020',
'unstructured': 'Palaniswamy, S. et al. Could vitamin D reduce obesity-associated '
'inflammation? Observational and Mendelian randomization study. Am. J. '
'Clin. Nutr. 111(5), 1036–1047. https://doi.org/10.1093/ajcn/nqaa056 '
'(2020).',
'journal-title': 'Am. J. Clin. Nutr.'},
{ 'issue': '1',
'key': '9785_CR22',
'doi-asserted-by': 'publisher',
'first-page': '33',
'DOI': '10.1007/s11739-011-0559-x',
'volume': '8',
'author': 'A Bellia',
'year': '2013',
'unstructured': 'Bellia, A. et al. Serum 25-hydroxyvitamin D levels are inversely '
'associated with systemic inflammation in severe obese subjects. Intern. '
'Emerg. Med. 8(1), 33–40. https://doi.org/10.1007/s11739-011-0559-x '
'(2013).',
'journal-title': 'Intern. Emerg. Med.'},
{ 'issue': '3',
'key': '9785_CR23',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0092614',
'volume': '9',
'author': 'RA Ghashut',
'year': '2014',
'unstructured': 'Ghashut, R. A., Talwar, D., Kinsella, J., Duncan, A. & McMillan, D. C. '
'The effect of the systemic inflammatory response on plasma vitamin 25 '
'(OH) D concentrations adjusted for albumin. PLoS\xa0One 9(3), e92614. '
'https://doi.org/10.1371/journal.pone.0092614 (2014).',
'journal-title': 'PLoS\xa0One'},
{ 'issue': '4',
'key': '9785_CR24',
'doi-asserted-by': 'publisher',
'first-page': '226',
'DOI': '10.1016/j.coviro.2011.07.002',
'volume': '1',
'author': 'T Aoshi',
'year': '2011',
'unstructured': 'Aoshi, T., Koyama, S., Kobiyama, K., Akira, S. & Ishii, K. J. Innate and '
'adaptive immune responses to viral infection and vaccination. Curr. '
'Opin. Virol. 1(4), 226–232. https://doi.org/10.1016/j.coviro.2011.07.002 '
'(2011).',
'journal-title': 'Curr. Opin. Virol.'},
{ 'issue': '7821',
'key': '9785_CR25',
'doi-asserted-by': 'publisher',
'first-page': '457',
'DOI': '10.1038/s41586-020-2550-z',
'volume': '584',
'author': 'N Le Bert',
'year': '2020',
'unstructured': 'Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of '
'COVID-19 and SARS, and uninfected controls. Nature 584(7821), 457–462. '
'https://doi.org/10.1038/s41586-020-2550-z (2020).',
'journal-title': 'Nature'},
{ 'issue': '6',
'key': '9785_CR26',
'doi-asserted-by': 'publisher',
'first-page': '971',
'DOI': '10.1016/j.immuni.2020.04.023',
'volume': '52',
'author': 'L Ni',
'year': '2020',
'unstructured': 'Ni, L. et al. Detection of SARS-CoV-2-specific humoral and cellular '
'immunity in COVID-19 convalescent individuals. Immunity 52(6), '
'971-977.e3. https://doi.org/10.1016/j.immuni.2020.04.023 (2020).',
'journal-title': 'Immunity'},
{ 'issue': '16',
'key': '9785_CR27',
'doi-asserted-by': 'publisher',
'first-page': '2027',
'DOI': '10.1093/cid/ciaa344',
'volume': '71',
'author': 'J Zhao',
'year': '2020',
'unstructured': 'Zhao, J. et al. Antibody responses to SARS-CoV-2 in patients with novel '
'coronavirus disease 2019. Clin. Infect. Dis. 71(16), 2027–2034. '
'https://doi.org/10.1093/cid/ciaa344 (2020).',
'journal-title': 'Clin. Infect. Dis.'},
{ 'issue': '8',
'key': '9785_CR28',
'doi-asserted-by': 'publisher',
'first-page': '1200',
'DOI': '10.1038/s41591-020-0965-6',
'volume': '26',
'author': 'QX Long',
'year': '2020',
'unstructured': 'Long, Q. X. et al. Clinical and immunological assessment of asymptomatic '
'SARS-CoV-2 infections. Nat. Med. 26(8), 1200–1204. '
'https://doi.org/10.1038/s41591-020-0965-6 (2020).',
'journal-title': 'Nat. Med.'},
{ 'issue': '2',
'key': '9785_CR29',
'doi-asserted-by': 'publisher',
'first-page': 'e55',
'DOI': '10.1016/j.jinf.2020.04.019',
'volume': '81',
'author': 'YL Lee',
'year': '2020',
'unstructured': 'Lee, Y. L. et al. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies '
'among COVID-19 patients. J. Infect. 81(2), e55–e58. '
'https://doi.org/10.1016/j.jinf.2020.04.019 (2020).',
'journal-title': 'J. Infect.'},
{ 'issue': '11',
'key': '9785_CR30',
'doi-asserted-by': 'publisher',
'first-page': '1085',
'DOI': '10.1056/NEJMc2025179',
'volume': '383',
'author': 'FJ Ibarrondo',
'year': '2020',
'unstructured': 'Ibarrondo, F. J. et al. Rapid decay of anti-SARS-CoV-2 antibodies in '
'persons with mild covid-19. N. Engl. J. Med. 383(11), 1085–1087. '
'https://doi.org/10.1056/NEJMc2025179 (2020).',
'journal-title': 'N. Engl. J. Med.'},
{ 'issue': '2',
'key': '9785_CR31',
'doi-asserted-by': 'publisher',
'first-page': '225',
'DOI': '10.1016/s1074-7613(03)00208-5',
'volume': '19',
'author': 'G Jego',
'year': '2003',
'unstructured': 'Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell '
'differentiation through type I interferon and interleukin 6. Immunity '
'19(2), 225–234. https://doi.org/10.1016/s1074-7613(03)00208-5 (2003).',
'journal-title': 'Immunity'},
{ 'issue': '6',
'key': '9785_CR32',
'doi-asserted-by': 'publisher',
'first-page': '808',
'DOI': '10.1016/j.jiac.2021.01.006',
'volume': '27',
'author': 'S Kutsuna',
'year': '2021',
'unstructured': 'Kutsuna, S. et al. Factors associated with anti-SARS-CoV-2 IgG antibody '
'production in patients convalescing from COVID-19. J. Infect. Chemother. '
'27(6), 808–813. https://doi.org/10.1016/j.jiac.2021.01.006 (2021).',
'journal-title': 'J. Infect. Chemother.'},
{ 'key': '9785_CR33',
'doi-asserted-by': 'publisher',
'first-page': '335',
'DOI': '10.1146/annurev-immunol-041015-055605',
'volume': '34',
'author': 'CG Vinuesa',
'year': '2016',
'unstructured': 'Vinuesa, C. G., Linterman, M. A., Yu, D. & MacLennan, I. C. Follicular '
'helper T cells. Annu. Rev. Immunol. 34, 335–368. '
'https://doi.org/10.1146/annurev-immunol-041015-055605 (2016).',
'journal-title': 'Annu. Rev. Immunol.'},
{ 'issue': '4',
'key': '9785_CR34',
'doi-asserted-by': 'publisher',
'first-page': '2004234',
'DOI': '10.1183/13993003.04234-2020',
'volume': '57',
'author': 'AA Faniyi',
'year': '2021',
'unstructured': 'Faniyi, A. A. et al. Vitamin D status and seroconversion for COVID-19 in '
'UK healthcare workers. Eur. Respir. J. 57(4), 2004234. '
'https://doi.org/10.1183/13993003.04234-2020 (2021).',
'journal-title': 'Eur. Respir. J.'},
{ 'issue': '9',
'key': '9785_CR35',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0239252',
'volume': '15',
'author': 'HW Kaufman',
'year': '2020',
'unstructured': 'Kaufman, H. W., Niles, J. K., Kroll, M. H., Bi, C. & Holick, M. F. '
'SARS-CoV-2 positivity rates associated with circulating '
'25-hydroxyvitamin D levels. PLoS\xa0One 15(9), e0239252. '
'https://doi.org/10.1371/journal.pone.0239252 (2020).',
'journal-title': 'PLoS\xa0One'},
{ 'issue': '5',
'key': '9785_CR36',
'doi-asserted-by': 'publisher',
'first-page': '2992',
'DOI': '10.1002/jmv.26832',
'volume': '93',
'author': 'M Demir',
'year': '2021',
'unstructured': 'Demir, M., Demir, F. & Aygun, H. Vitamin D deficiency is associated with '
'COVID-19 positivity and severity of the disease. J. Med. Virol. 93(5), '
'2992–2999. https://doi.org/10.1002/jmv.26832 (2021).',
'journal-title': 'J. Med. Virol.'},
{ 'issue': '1',
'key': '9785_CR37',
'doi-asserted-by': 'publisher',
'first-page': '207',
'DOI': '10.1007/s00404-013-2735-x',
'volume': '288',
'author': 'AG Kebapcilar',
'year': '2013',
'unstructured': 'Kebapcilar, A. G. et al. Relationship between mean platelet volume and '
'low-grade systemic coagulation with vitamin D deficiency in primary '
'ovarian insufficiency. Arch. Gynecol. Obstet. 288(1), 207–212. '
'https://doi.org/10.1007/s00404-013-2735-x (2013).',
'journal-title': 'Arch. Gynecol. Obstet.'},
{ 'issue': '5',
'key': '9785_CR38',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/jamanetworkopen.2021.11634',
'volume': '4',
'author': 'Y Li',
'year': '2021',
'unstructured': 'Li, Y., Tong, C. H., Bare, L. A. & Devlin, J. J. Assessment of the '
'association of vitamin D level with SARS-CoV-2 seropositivity among '
'working-age adults. JAMA Netw. Open. 4(5), e2111634. '
'https://doi.org/10.1001/jamanetworkopen.2021.11634 (2021).',
'journal-title': 'JAMA Netw. Open.'},
{ 'issue': '11',
'key': '9785_CR39',
'doi-asserted-by': 'publisher',
'DOI': '10.1111/ijcp.14675',
'volume': '75',
'author': 'R Ghasemian',
'year': '2021',
'unstructured': 'Ghasemian, R. et al. The role of vitamin D in the age of COVID-19: A '
'systematic review and meta-analysis. Int. J. Clin. Pract. 75(11), '
'e14675. https://doi.org/10.1111/ijcp.14675 (2021).',
'journal-title': 'Int. J. Clin. Pract.'},
{ 'issue': '1',
'key': '9785_CR40',
'doi-asserted-by': 'publisher',
'first-page': '20191',
'DOI': '10.1038/s41598-020-77093-z',
'volume': '10',
'author': 'A Jain',
'year': '2020',
'unstructured': 'Jain, A. et al. Analysis of vitamin D level among asymptomatic and '
'critically ill COVID-19 patients and its correlation with inflammatory '
'markers. Sci. Rep. 10(1), 20191. '
'https://doi.org/10.1038/s41598-020-77093-z (2020).',
'journal-title': 'Sci. Rep.'},
{ 'issue': '3',
'key': '9785_CR41',
'doi-asserted-by': 'publisher',
'first-page': '227',
'DOI': '10.5578/tt.70027',
'volume': '68',
'author': 'B Kerget',
'year': '2020',
'unstructured': 'Kerget, B. et al. Evaluation of the relationship of serum vitamin D '
'levels in COVID-19 patients with clinical course and prognosis. COVID-19 '
'hastalarında serum vitamin D düzeyinin klinik seyir ve prognozla '
'ilişkisinin değerlendirilmesi. Tuberk Toraks. 68(3), 227–235. '
'https://doi.org/10.5578/tt.70027 (2020).',
'journal-title': 'Tuberk Toraks.'},
{ 'issue': '2',
'key': '9785_CR42',
'doi-asserted-by': 'publisher',
'first-page': '733',
'DOI': '10.1002/jmv.26360',
'volume': '93',
'author': 'R Munshi',
'year': '2021',
'unstructured': 'Munshi, R. et al. Vitamin D insufficiency as a potential culprit in '
'critical COVID-19 patients. J. Med. Virol. 93(2), 733–740. '
'https://doi.org/10.1002/jmv.26360 (2021).',
'journal-title': 'J. Med. Virol.'},
{ 'issue': '1',
'key': '9785_CR43',
'doi-asserted-by': 'publisher',
'first-page': '545',
'DOI': '10.1007/s00394-020-02372-4',
'volume': '60',
'author': 'CE Hastie',
'year': '2021',
'unstructured': 'Hastie, C. E., Pell, J. P. & Sattar, N. Vitamin D and COVID-19 infection '
'and mortality in UK Biobank. Eur. J. Nutr. 60(1), 545–548. '
'https://doi.org/10.1007/s00394-020-02372-4 (2021).',
'journal-title': 'Eur. J. Nutr.'},
{ 'issue': '1149',
'key': '9785_CR44',
'doi-asserted-by': 'publisher',
'first-page': '442',
'DOI': '10.1136/postgradmedj-2020-138712',
'volume': '97',
'author': 'V Baktash',
'year': '2021',
'unstructured': 'Baktash, V. et al. Vitamin D status and outcomes for hospitalised older '
'patients with COVID-19. Postgrad. Med. J. 97(1149), 442–447. '
'https://doi.org/10.1136/postgradmedj-2020-138712 (2021).',
'journal-title': 'Postgrad. Med. J.'},
{ 'issue': '4',
'key': '9785_CR45',
'doi-asserted-by': 'publisher',
'first-page': '765',
'DOI': '10.1007/s40618-020-01370-x',
'volume': '44',
'author': 'GE Carpagnano',
'year': '2021',
'unstructured': 'Carpagnano, G. E. et al. Vitamin D deficiency as a predictor of poor '
'prognosis in patients with acute respiratory failure due to COVID-19. J. '
'Endocrinol. Investig. 44(4), 765–771. '
'https://doi.org/10.1007/s40618-020-01370-x (2021).',
'journal-title': 'J. Endocrinol. Investig.'},
{ 'issue': '3',
'key': '9785_CR46',
'doi-asserted-by': 'publisher',
'first-page': '190',
'DOI': '10.1016/j.cyto.2008.12.009',
'volume': '45',
'author': 'C Almerighi',
'year': '2009',
'unstructured': 'Almerighi, C. et al. 1Alpha,25-dihydroxyvitamin D3 inhibits '
'CD40L-induced pro-inflammatory and immunomodulatory activity in human '
'monocytes. Cytokine 45(3), 190–197. '
'https://doi.org/10.1016/j.cyto.2008.12.009 (2009).',
'journal-title': 'Cytokine'},
{ 'issue': '11',
'key': '9785_CR47',
'doi-asserted-by': 'publisher',
'first-page': '2409',
'DOI': '10.1002/jmv.26097',
'volume': '92',
'author': 'N Ali',
'year': '2020',
'unstructured': 'Ali, N. Elevated level of C-reactive protein may be an early marker to '
'predict risk for severity of COVID-19. J. Med. Virol. 92(11), 2409–2411. '
'https://doi.org/10.1002/jmv.26097 (2020).',
'journal-title': 'J. Med. Virol.'},
{ 'issue': '12',
'key': '9785_CR48',
'doi-asserted-by': 'publisher',
'first-page': '1465',
'DOI': '10.5858/arpa.2020-0471-SA',
'volume': '144',
'author': 'Y Tjendra',
'year': '2020',
'unstructured': 'Tjendra, Y. et al. Predicting disease severity and outcome in COVID-19 '
'patients: A review of multiple biomarkers. Arch. Pathol. Lab. Med. '
'144(12), 1465–1474. https://doi.org/10.5858/arpa.2020-0471-SA (2020).',
'journal-title': 'Arch. Pathol. Lab. Med.'},
{ 'issue': '7821',
'key': '9785_CR49',
'doi-asserted-by': 'publisher',
'first-page': '437',
'DOI': '10.1038/s41586-020-2456-9',
'volume': '584',
'author': 'DF Robbiani',
'year': '2020',
'unstructured': 'Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in '
'convalescent individuals. Nature 584(7821), 437–442. '
'https://doi.org/10.1038/s41586-020-2456-9 (2020).',
'journal-title': 'Nature'},
{ 'key': '9785_CR50',
'doi-asserted-by': 'publisher',
'author': 'AM Sholukh',
'year': '2020',
'unstructured': 'Sholukh, A. M. et al. Evaluation of SARS-CoV-2 neutralization assays for '
'antibody monitoring in natural infection and vaccine trials. Preprint. '
'medRxiv. https://doi.org/10.1101/2020.12.07.20245431 (2020).',
'journal-title': 'medRxiv.',
'DOI': '10.1101/2020.12.07.20245431'},
{ 'issue': '1',
'key': '9785_CR51',
'doi-asserted-by': 'publisher',
'first-page': '6044',
'DOI': '10.1038/s41467-020-19943-y',
'volume': '11',
'author': 'K Li',
'year': '2020',
'unstructured': 'Li, K. et al. Dynamic changes in anti-SARS-CoV-2 antibodies during '
'SARS-CoV-2 infection and recovery from COVID-19. Nat. Commun. 11(1), '
'6044. https://doi.org/10.1038/s41467-020-19943-y (2020).',
'journal-title': 'Nat. Commun.'},
{ 'issue': '5',
'key': '9785_CR52',
'doi-asserted-by': 'publisher',
'first-page': '565',
'DOI': '10.1016/S1473-3099(20)30196-1',
'volume': '20',
'author': 'KK To',
'year': '2020',
'unstructured': 'To, K. K. et al. Temporal profiles of viral load in posterior '
'oropharyngeal saliva samples and serum antibody responses during '
'infection by SARS-CoV-2: An observational cohort study. Lancet Infect. '
'Dis. 20(5), 565–574. https://doi.org/10.1016/S1473-3099(20)30196-1 '
'(2020).',
'journal-title': 'Lancet Infect. Dis.'},
{ 'issue': '596',
'key': '9785_CR53',
'doi-asserted-by': 'publisher',
'first-page': 'eabf8654',
'DOI': '10.1126/scitranslmed.abf8654',
'volume': '13',
'author': 'W Hoepel',
'year': '2021',
'unstructured': 'Hoepel, W. et al. High titers and low fucosylation of early human '
'anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci. '
'Transl. Med. 13(596), eabf8654. '
'https://doi.org/10.1126/scitranslmed.abf8654 (2021).',
'journal-title': 'Sci. Transl. Med.'},
{ 'issue': '1',
'key': '9785_CR54',
'doi-asserted-by': 'publisher',
'first-page': '113',
'DOI': '10.1038/s41392-021-00525-3',
'volume': '6',
'author': 'L Gao',
'year': '2021',
'unstructured': 'Gao, L. et al. The dichotomous and incomplete adaptive immunity in '
'COVID-19 patients with different disease severity. Signal Transduct. '
'Target Ther. 6(1), 113. https://doi.org/10.1038/s41392-021-00525-3 '
'(2021).',
'journal-title': 'Signal Transduct. Target Ther.'},
{ 'issue': '9',
'key': '9785_CR55',
'doi-asserted-by': 'publisher',
'first-page': 'e1619',
'DOI': '10.1002/onco.13828',
'volume': '26',
'author': 'M Esperança-Martins',
'year': '2021',
'unstructured': 'Esperança-Martins, M. et al. Humoral immune response of '
'SARS-CoV-2-infected patients with cancer: Influencing factors and '
'mechanisms. Oncologist. 26(9), e1619–e1632. '
'https://doi.org/10.1002/onco.13828 (2021).',
'journal-title': 'Oncologist.'},
{ 'issue': '1',
'key': '9785_CR56',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pntd.0010102',
'volume': '16',
'author': 'A Akter',
'year': '2022',
'unstructured': 'Akter, A. et al. Disease characteristics and serological responses in '
'patients with differing severity of COVID-19 infection: A longitudinal '
'cohort study in Dhaka, Bangladesh. PLoS Negl. Trop. Dis. 16(1), '
'e0010102. https://doi.org/10.1371/journal.pntd.0010102 (2022).',
'journal-title': 'PLoS Negl. Trop. Dis.'},
{ 'issue': '1',
'key': '9785_CR57',
'doi-asserted-by': 'publisher',
'first-page': '80',
'DOI': '10.3390/v14010080',
'volume': '14',
'author': 'X Li',
'year': '2022',
'unstructured': 'Li, X. et al. Patient and clinical factors at admission affect the '
'levels of neutralizing antibodies six months after recovering from '
'COVID-19. Viruses 14(1), 80. https://doi.org/10.3390/v14010080 (2022).',
'journal-title': 'Viruses'},
{ 'issue': '4',
'key': '9785_CR58',
'doi-asserted-by': 'publisher',
'first-page': 'e00362',
'DOI': '10.1128/mSphere.00362-20',
'volume': '5',
'author': 'Y Wu',
'year': '2020',
'unstructured': 'Wu, Y. et al. Clinical characteristics and immune injury mechanisms in '
'71 patients with COVID-19. mSphere. 5(4), e00362-e420. '
'https://doi.org/10.1128/mSphere.00362-20 (2020).',
'journal-title': 'mSphere.'},
{ 'issue': '10',
'key': '9785_CR59',
'doi-asserted-by': 'publisher',
'DOI': '10.1002/jcla.23483',
'volume': '34',
'author': 'G Zhao',
'year': '2020',
'unstructured': 'Zhao, G. et al. A comparative study of the laboratory features of '
'COVID-19 and other viral pneumonias in the recovery stage. J. Clin. Lab. '
'Anal. 34(10), e23483. https://doi.org/10.1002/jcla.23483 (2020).',
'journal-title': 'J. Clin. Lab. Anal.'},
{ 'key': '9785_CR60',
'doi-asserted-by': 'publisher',
'author': 'A Barassi',
'year': '2021',
'unstructured': 'Barassi, A. et al. Vitamin D in severe acute respiratory syndrome '
'coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation '
'support. Panminerva Med. https://doi.org/10.23736/S0031-0808.21.04277-4 '
'(2021).',
'journal-title': 'Panminerva Med.',
'DOI': '10.23736/S0031-0808.21.04277-4'},
{ 'issue': '12',
'key': '9785_CR61',
'doi-asserted-by': 'publisher',
'first-page': '2025',
'DOI': '10.1002/eji.202048970',
'volume': '50',
'author': 'P Figueiredo-Campos',
'year': '2020',
'unstructured': 'Figueiredo-Campos, P. et al. Seroprevalence of anti-SARS-CoV-2 '
'antibodies in COVID-19 patients and healthy volunteers up to 6 months '
'post disease onset. Eur. J. Immunol. 50(12), 2025–2040. '
'https://doi.org/10.1002/eji.202048970 (2020).',
'journal-title': 'Eur. J. Immunol.'},
{ 'issue': '10',
'key': '9785_CR62',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0241104',
'volume': '15',
'author': 'E Marklund',
'year': '2020',
'unstructured': 'Marklund, E. et al. Serum-IgG responses to SARS-CoV-2 after mild and '
'severe COVID-19 infection and analysis of IgG non-responders. PLoS ONE '
'15(10), e0241104. https://doi.org/10.1371/journal.pone.0241104 (2020).',
'journal-title': 'PLoS ONE'},
{ 'issue': '3',
'key': '9785_CR63',
'doi-asserted-by': 'publisher',
'first-page': '482',
'DOI': '10.1007/s11427-020-1805-0',
'volume': '64',
'author': 'H Ma',
'year': '2021',
'unstructured': 'Ma, H. et al. Decline of SARS-CoV-2-specific IgG, IgM and IgA in '
'convalescent COVID-19 patients within 100 days after hospital discharge. '
'Sci. China Life Sci. 64(3), 482–485. '
'https://doi.org/10.1007/s11427-020-1805-0 (2021).',
'journal-title': 'Sci. China Life Sci.'}],
'container-title': ['Scientific Reports'],
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.nature.com/articles/s41598-022-09785-7.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.nature.com/articles/s41598-022-09785-7',
'content-type': 'text/html',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.nature.com/articles/s41598-022-09785-7.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 4, 5]],
'date-time': '2022-04-05T17:16:52Z',
'timestamp': 1649179012000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.nature.com/articles/s41598-022-09785-7'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 4, 5]]},
'references-count': 63,
'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2022, 12]]}},
'alternative-id': ['9785'],
'URL': 'http://dx.doi.org/10.1038/s41598-022-09785-7',
'relation': {},
'ISSN': ['2045-2322'],
'issn-type': [{'value': '2045-2322', 'type': 'electronic'}],
'subject': ['Multidisciplinary'],
'published': {'date-parts': [[2022, 4, 5]]},
'assertion': [ { 'value': '29 November 2021',
'order': 1,
'name': 'received',
'label': 'Received',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': '28 March 2022',
'order': 2,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': '5 April 2022',
'order': 3,
'name': 'first_online',
'label': 'First Online',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': 'The authors declare no competing interests.',
'order': 1,
'name': 'Ethics',
'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}],
'article-number': '5699'}
